238 related articles for article (PubMed ID: 34244212)
1. Cholesterol Auxotrophy as a Targetable Vulnerability in Clear Cell Renal Cell Carcinoma.
Riscal R; Bull CJ; Mesaros C; Finan JM; Carens M; Ho ES; Xu JP; Godfrey J; Brennan P; Johansson M; Purdue MP; Chanock SJ; Mariosa D; Timpson NJ; Vincent EE; Keith B; Blair IA; Skuli N; Simon MC
Cancer Discov; 2021 Dec; 11(12):3106-3125. PubMed ID: 34244212
[TBL] [Abstract][Full Text] [Related]
2. Bile Acid Metabolism Mediates Cholesterol Homeostasis and Promotes Tumorigenesis in Clear Cell Renal Cell Carcinoma.
Riscal R; Gardner SM; Coffey NJ; Carens M; Mesaros C; Xu JP; Xue Y; Davis L; Demczyszyn S; Vogt A; Olia A; Finan JM; Godfrey J; Schultz DC; Blair IA; Keith B; Marmorstein R; Skuli N; Simon MC
Cancer Res; 2024 May; 84(10):1570-1582. PubMed ID: 38417134
[TBL] [Abstract][Full Text] [Related]
3. TAGLN2 Promotes the Proliferation, Migration, Invasion, and EMT of Clear Cell Renal Cell Carcinoma Through the PI3K/Akt Signaling Pathway.
He Y; Zhang B; Han D; Du Y; Zhang X; Wang H; Yue Z; Shang P
Biochem Genet; 2023 Aug; 61(4):1265-1281. PubMed ID: 36547768
[TBL] [Abstract][Full Text] [Related]
4. AUP1 regulates lipid metabolism and induces lipid accumulation to accelerate the progression of renal clear cell carcinoma.
Chen C; Zhao W; Lu X; Ma Y; Zhang P; Wang Z; Cui Z; Xia Q
Cancer Sci; 2022 Aug; 113(8):2600-2615. PubMed ID: 35633317
[TBL] [Abstract][Full Text] [Related]
5. FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway.
Lv Q; Wang G; Zhang Y; Han X; Li H; Le W; Zhang M; Ma C; Wang P; Ding Q
Int J Oncol; 2019 Apr; 54(4):1221-1232. PubMed ID: 30968158
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma.
Xu GH; Lou N; Shi HC; Xu YC; Ruan HL; Xiao W; Liu L; Li X; Xiao HB; Qiu B; Bao L; Yuan CF; Zhou YL; Hu WJ; Chen K; Yang HM; Zhang XP
BMC Cancer; 2018 Jan; 18(1):88. PubMed ID: 29357836
[TBL] [Abstract][Full Text] [Related]
7. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
[TBL] [Abstract][Full Text] [Related]
8. Overexpression CPT1A reduces lipid accumulation via PPARα/CD36 axis to suppress the cell proliferation in ccRCC.
Yang H; Zhao H; Ren Z; Yi X; Zhang Q; Yang Z; Kuang Y; Zhu Y
Acta Biochim Biophys Sin (Shanghai); 2022 Jan; 54(2):220-231. PubMed ID: 35130611
[TBL] [Abstract][Full Text] [Related]
9. Suppressive effects of iron chelation in clear cell renal cell carcinoma and their dependency on VHL inactivation.
Greene CJ; Sharma NJ; Fiorica PN; Forrester E; Smith GJ; Gross KW; Kauffman EC
Free Radic Biol Med; 2019 Mar; 133():295-309. PubMed ID: 30553971
[TBL] [Abstract][Full Text] [Related]
10. Exosomal microRNA-15a from ACHN cells aggravates clear cell renal cell carcinoma via the BTG2/PI3K/AKT axis.
Li DY; Lin FF; Li GP; Zeng FC
Kaohsiung J Med Sci; 2021 Nov; 37(11):973-982. PubMed ID: 34337864
[TBL] [Abstract][Full Text] [Related]
11. Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?
Wu G; Wang Q; Xu Y; Li J; Zhang H; Qi G; Xia Q
Cell Death Dis; 2019 May; 10(6):416. PubMed ID: 31138790
[TBL] [Abstract][Full Text] [Related]
12. NOTCH1 functions as an oncogene by regulating the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma.
Liu S; Ma X; Ai Q; Huang Q; Shi T; Zhu M; Wang B; Zhang X
Urol Oncol; 2013 Aug; 31(6):938-48. PubMed ID: 21993533
[TBL] [Abstract][Full Text] [Related]
13. PTPN3 Inhibits the Growth and Metastasis of Clear Cell Renal Cell Carcinoma via Inhibition of PI3K/AKT Signaling.
Peng XS; Yang JP; Qiang YY; Sun R; Cao Y; Zheng LS; Peng LX; Lang YH; Mei Y; Li CZ; Meng DF; Liu ZJ; Wang MD; Zhou FJ; Huang BJ; Qian CN
Mol Cancer Res; 2020 Jun; 18(6):903-912. PubMed ID: 32169891
[TBL] [Abstract][Full Text] [Related]
14. Uptake of HDL-cholesterol contributes to lipid accumulation in clear cell renal cell carcinoma.
Kim J; Thompson B; Han S; Lotan Y; McDonald JG; Ye J
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Dec; 1864(12):158525. PubMed ID: 31513923
[TBL] [Abstract][Full Text] [Related]
15. HOXA6 inhibits cell proliferation and induces apoptosis by suppressing the PI3K/Akt signaling pathway in clear cell renal cell carcinoma.
Wu F; Wu S; Tong H; He W; Gou X
Int J Oncol; 2019 Jun; 54(6):2095-2105. PubMed ID: 31081053
[TBL] [Abstract][Full Text] [Related]
16. Bridging the gap between clear cell renal cell carcinoma and cutaneous melanoma: the role of SCARB1 in dysregulated cholesterol metabolism.
Song L; Wang S; Zhang X; Song N; Lu Y; Qin C
Aging (Albany NY); 2023 Oct; 15(19):10370-10388. PubMed ID: 37801479
[TBL] [Abstract][Full Text] [Related]
17. ETV4 is a theranostic target in clear cell renal cell carcinoma that promotes metastasis by activating the pro-metastatic gene FOSL1 in a PI3K-AKT dependent manner.
Xu L; Hu H; Zheng LS; Wang MY; Mei Y; Peng LX; Qiang YY; Li CZ; Meng DF; Wang MD; Liu ZJ; Li XJ; Huang BJ; Qian CN
Cancer Lett; 2020 Jul; 482():74-89. PubMed ID: 32305558
[TBL] [Abstract][Full Text] [Related]
18. Notch1 activation promotes renal cell carcinoma growth via PI3K/Akt signaling.
Xu L; Zhu Y; Xu J; Wu K; Li J; Xu W; Liu H; Wang S; Yin H; Chen L; Wang G; Lin Z
Cancer Sci; 2012 Jul; 103(7):1253-8. PubMed ID: 22463491
[TBL] [Abstract][Full Text] [Related]
19. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
Huang J; Wang X; Wen G; Ren Y
Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
[TBL] [Abstract][Full Text] [Related]
20. Scavenger receptor BI promotes cytoplasmic accumulation of lipoproteins in clear-cell renal cell carcinoma.
Velagapudi S; Schraml P; Yalcinkaya M; Bolck HA; Rohrer L; Moch H; von Eckardstein A
J Lipid Res; 2018 Nov; 59(11):2188-2201. PubMed ID: 30173145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
